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Abstract
Providencia rettgeri (P. rettgeri) is a clinically significant Gram-negative bacterium of genus Providencia, and 
commonly associated with hospital-acquired infection like urinary tract infection (UTI), gastroenteritis, and ocular 
infections. Present study was designed to evaluate the effect of biofield treatment on P. rettgeri against antimicrobial 
susceptibility, biochemical reaction pattern, biotype number, and 16S rDNA sequence. The samples of P. rettgeri (ATCC 
9250) were divided into three groups: Gr.I (control), Gr.II (treatment, revived), and Gr.III (treatment, lyophilized). The 
Gr.II and III were treated with Mr. Trivedi’s biofield, and then subsequently characterized for antimicrobial susceptibility, 
minimum inhibitory concentration (MIC), biochemical reactions, and biotype numbering. The 16S rDNA sequencing 
was carried out to correlate the phylogenetic relationship of P. rettgeri with other bacterial species. The treated cells of 
P. rettgeri showed an alteration in susceptibility of about 50% and 53.3% tested antimicrobials of Gr.II on day 5 and 10, 
respectively; and 53.3% of tested antimicrobials of Gr.III on day 10. MIC results showed a significant decrease in MIC 
values of 53.1, 56.3, and 56.3% antimicrobials in Gr.II on day 5, Gr.II on day 10, and Gr.III on day 10, respectively, as 
compared to control. The significant changes in biochemical reactions and biotype numbers were also observed in all 
the treated groups of P. rettgeri. Based on nucleotides homology and phylogenetic analysis the P. rettgeri was found to 
be Proteus mirabilis (GenBank Accession Number: AY820623) and nearest homolog species was found to be Proteus 
vulgaris (Accession No. DQ499636). These findings suggest that biofield treatment can prevent the emergence of 
absolute resistance of existing antimicrobials to P. rettgeri. 
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Introduction
Presently, several microbes have been acquired the resistance 
to number of antimicrobial agents that were successfully treat the 
microbial infections earlier. The antimicrobial resistant microbes 
whether bacteria, fungi, viruses or parasites can survive in regular 
antimicrobial drugs therapy. The frequent and improper use and misuse 
of antimicrobial drugs accelerate the emergence of drug-resistant 
microbes, which were further spread by poor sanitary conditions and 
meager infection control [1]. Antimicrobial drugs prescribed in nearly 
all Providencia infections caused by five species: Providencia rettgeri, P. 
alcalifaciens, P. rustigianii, P. stuartii, and P. heimbachae. The P. rettgeri 
is a clinically significant, urease-producing, Gram-negative Bacillus 
and usually found in both water and land atmospheres. It is generally 
associated with opportunistic infections in humans such as traveler’s 
diarrhea, urinary tract infections (UTI), skin infection, gastroenteritis, 
conjunctivitis, and endophthalmitis. The occurrence of P. rettgeri 
infection is common throughout the world with 6–33% of mortality 
rate, which is even greater in polymicrobial infection [2,3]. Recently, 
P. rettgeri has acquired antimicrobial resistance due to producing 
β-lactamase enzymes [4,5]. Therefore, due to the clinical significance 
of P. rettgeri, development of effective antimicrobial therapy is very 
needful for human health. As such, no medication is available to cure 
the resistant strain of microbe but an alternative approach known 
as biofield treatment is recently reported to alter the antimicrobial 
sensitivity in different microorganism [6]. 
The law of mass-energy inter-conversion is existed in the literature 
for more than 300 years, and the thought was initially reported by 
Hasenohrl followed by Einstein [7,8]. However, the conversion of mass 
into energy is well established, but its inversion i.e., energy into mass 
has not yet proven scientifically. Furthermore, the energy can exists in 
several forms such as kinetic, potential, electrical, magnetic, and nuclear. 
Similarly, the human nervous system consists the energy in the form 
of electrical signals [9,10]. Thus, human has the ability to harness the 
energy from environment or universe and can transmit into any leaving 
or nonliving object(s) around the Globe. The objects always receive the 
energy and responding into useful way that is called biofield energy and 
the process is known as biofield treatment. Whenever these electrical 
signals fluctuate with time, the magnetic field generates as per the 
Ampere-Maxwell law, and cumulatively known as electromagnetic field. 
Hence, the electromagnetic field being generated from the human body 
is known as biofield [11]. Mr. Mahendra Trivedi’s biofield treatment has 
shown to transform the characteristics non-living and living things in 
several fields such as material science [12–17], agriculture [18–20], and 
biotechnology [21,22]. The biofield treatment has considerably altered 
the sensitivity of antimicrobials to some microbes [6,23,24]. 
By conceiving the challenges of antimicrobial resistance in P. 
rettgeri, and advantages of biofield treatment; this work was undertaken 
to evaluate the effects of biofield treatment on antimicrobials sensitivity, 
biotype number based on various biochemical reactions, and 16S rDNA 
gene sequencing of P. rettgeri. 
Materials and Methods
The sample vial of P. rettgeri [American Type Culture Collection 
(ATCC) 9250] was procured from MicroBioLogics, Inc., USA, and 
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stored as per the suggested storage conditions until further use. The 
antimicrobial susceptibility, biochemical reactions, and biotype 
number were evaluated on MicroScan Walk-Away® (Dade Behring 
Inc., West Sacramento, CA) using Negative Breakpoint Combo 30 
(NBPC30) panel. The 16S rDNA sequencing study was carried out in 
Gr. III sample using Ultrapure Genomic DNA Prep Kit; Cat KT 83 
(Bangalore Genei, India).
Biofield treatment
The samples of P. rettgeri was divided in three groups: Gr.I 
(control), Gr.II (treatment, revived), and Gr.III (treatment, lyophilized). 
Subsequently, the treatment groups (Gr. II and III) were received biofield 
treatment. The treatment groups were in sealed pack and handed over 
to Mr. Trivedi for biofield treatment under laboratory condition. Mr. 
Trivedi provided the treatment through his energy transmission process 
to the treated groups without touching the samples. Treated samples 
were assessed for antimicrobial sensitivity, biochemical reactions, and 
biotyping of P. rettgeri. The assays for Gr.II were assessed on day 5 and 
10, and Gr.III was assessed on day 10. The 16S rDNA gene sequencing 
of P. rettgeri was also carried out. 
Evaluation of antimicrobial susceptibility of P. rettgeri
Investigation of antimicrobial sensitivity of P. rettgeri was carried 
out with the help of automated instrument, MicroScan Walk-
Away® using Negative Breakpoint Combo 30 (NBPC30) panel, as 
per the manufacturer’s instructions [25]. The minimum inhibitory 
concentration (MIC) and a qualitative susceptibility like resistant 
(R), intermediate (I), susceptible (S), or inducible β-lactamases (IB) 
were determined by observing the lowest antimicrobial concentration 
showing growth inhibition [26]. The antimicrobial sensitivity study was 
carried out using following antimicrobials like amikacin, amoxicillin/
K-clavulanate, ampicillin/sulbactam, ampicillin, aztreonam, 
cefazolin, cefepime, cefotaxime, cefotetan, cefoxitin, ceftazidime, 
cefuroxime, ceftriaxone, cephalothin, chloramphenicol, ciprofloxacin, 
gatifloxacin, gentamicin, imipenem, levofloxacin, meropenem, 
moxifloxacin, nitrofurantoin, norfloxacin, piperacillin, piperacillin/
tazobactam, tetracycline, ticarcillin, tobramycin, and trimethoprim/
sulfamethoxazole. All these antimicrobials were purchased from 
Sigma-Aldrich, USA.
Biochemical studies
The biochemical studies of P. rettgeri were performed on MicroScan 
Walk-Away® [27,28]. Biochemical reactions patterns were carried out using 
32 biochemicals viz. acetamide, adonitol, arabinose, arginine, cetrimide, 
cephalothin, citrate, colistin, esculin hydrolysis, nitrofurantoin, glucose, 
hydrogen sulfide, indole, inositol, kanamycin, lysine, malonate, melibiose, 
nitrate, oxidation-fermentation media, galactosidase, ornithine, oxidase, 
raffinose, Rhamnose, sorbitol, sucrose, tartarate, tryptophan deaminase, 
tobramycin, urea, and Voges-Proskauer. All these biochemical were 
procured from Sigma-Aldrich, USA.
Biotype number
The biotype numbers of P. rettgeri was determined by automated 
MicroScan Walk-Away® processed panel data utilizing biochemical 
reactions [25].
Amplification and gene sequencing of 16S rDNA 
Genomic DNA was isolated and purified from treated group of P. 
rettgeri cells by using genomic purification Kit, as per the manufacturer’s 
instructions. The 16S rDNA gene (~1.5 kb) was amplified employing 
universal primers forward 5’-AGAGTTTGATCCTGGC-3’ and reverse 
5’-GGTTACCTTGTTACGACTT-3’. After that, the amplified products 
were subjected to gel electrophoresis on 1.0% agarose gel, stained with 
ethidium bromide, and visualized under UV light in a gel documentation 
unit (BioRad Laboratories, USA). The amplified fragment of PCR was 
purified from the agarose gel by DNA Gel Extraction Kit. Sequencing of 
amplified product was carried out on commercial basis from Bangalore 
Genei, India. The obtained 16S rDNA sequences data were aligned 
and compared with the sequences, available in Gene Bank database 
of National Center for Biotechnology Information (NCBI) using 
the algorithm BLASTn program. The multiple sequence alignment/
phylogenetic tree were constructed using MEGA 3.1 software using 
neighbour joining method [29].
Results 
Evaluation of antimicrobial susceptibility 
The results of biofield treatment on P. rettgeri in relation to sensitivity 
pattern and MIC of tested antimicrobials are summarized in Table 1 
and 2, respectively. The biofield treated cells of P. rettgeri exhibited an 
alteration in susceptibility of 50% and 53.3% of total antimicrobials 
in Gr.II on day 5 and 10, respectively; and alteration of 53.3% of total 
antimicrobials in Gr.III on 10th day, with about 2–4 folds decrease in the 
MIC values of respective antimicrobials. Briefly, amikacin, cefepime, 
chloramphenicol, gentamicin, and tobramycin were converted from 
S. No. Antimicrobial
Gr.I 
Control
Gr.II
day 5
Gr.II
day 10
Gr.III
day 10
1 Amikacin R S S S
2 Amoxicillin/K-clavulanate IB IB IB IB
3 Ampicillin/Sulbactam I IB IB IB
4 Ampicillin R R I IB
5 Aztreonam R IB IB IB
6 Cefazolin I IB IB IB
7 Cefepime R S S S
8 Cefotaxime R IB IB IB
9 Cefotetan R IB IB IB
10 Cefoxitin R IB IB IB
11 Ceftazidime R IB IB IB
12 Cefuroxime R IB IB IB
13 Ceftriaxone IB IB IB IB
14 Cephalothin R IB IB IB
15 Chloramphenicol R S S S
16 Ciprofloxacin S S S S
17 Gatifloxacin S S S S
18 Gentamicin R S S S
19 Imipenem S S S S
20 Levofloxacin S S S S
21 Meropenem S S S S
22 Moxifloxacin S S S S
23 Nitrofurantoin R R R R
24 Norfloxacin S S S S
25 Piperacillin IB IB IB IB
26 Piperacillin/Tazobactam IB IB IB IB
27 Tetracycline R R R R
28 Ticarcillin I IB IB IB
29 Tobramycin R S S S
30 Trimethoprim/Sulfamethoxazole S S S S
Gr: Group; I: Intermediate; S: Susceptible; R: Resistant; IB: Reduced Activity of 
Inducible β-lactamase
Table 1: Effect of biofield treatment on Providencia rettgeri to susceptibility pattern 
of selected antimicrobials.
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resistant (control) to susceptible in treated groups (Gr.II and Gr.III in 
all assessment). Similarly, cefotetan, cefoxitin, ceftazidime, cefuroxime, 
cefotaxime, cephalothin, and aztreonam were changed from resistant 
to inducible β-lactamase in entire treated groups. The sensitivity of 
ampicillin was altered from resistant to intermediate and inducible 
β-lactamase in Gr.II and III, respectively on day 10. Further, the 
ampicillin/sulbactam, cefazolin, and ticarcillin were converted from 
intermediate to inducible β-lactamase in all the treated groups. The 
MIC of all the above-mentioned antimicrobials were decreased about 
2-folds except the ticarcillin and cefotaxime that showed about 4-folds 
decrease in MIC value.
Organism identification by biochemical reactions
The biochemical reactions of P. rettgeri are reported in Table 3, 
revealed an alteration in biochemical reaction pattern as 12.1% of total 
biochemicals in Gr.II on day 5 and 10, and 48.5% of total biochemicals 
in Gr.III on day 10. Briefly, the cephalothin, kanamycin, and tobramycin 
biochemical reactions were converted from positive to negative reaction 
in entire treated groups (Gr.II on day 5 and 10 and Gr.III on day 10). 
Biochemicals such as arabinose, hydrogen sulfide, lysine, malonate, 
melibiose, galactosidase, ornithine, raffinose, Rhamnose, sorbitol, 
sucrose, and Voges-Proskauer were changed from positive to negative 
reaction only in Gr.III on day 10 with respect to control. Further, 
tartarate was converted from negative to positive reaction in Gr.II on 
day 5 only, and tryptophan was converted from negative to positive in 
Gr.II and Gr.III on day 10, as compared to control. 
Effect of biofield treatment on biotype number 
The biotype numbers of P. rettgeri was determined on MicroScan 
Walk-Away® processed panel, using biochemical reaction data. The 
result exhibited alteration in biotype number of P. rettgeri in the entire 
treated groups (on all assessment day) as compared to control (Table 4). 
16S rDNA gene sequencing
The 16S rDNA sequence was determined in P. rettgeri. The 
S. No. Antimicrobial
Gr.I 
Control
Gr.II
day 5
Gr.II
day 10
Gr.III
day 10
1 Amikacin >32 ≤16 ≤16 ≤16
2 Amoxicillin/ K-clavulanate ≤8/4 ≤8/4 ≤8/4 ≤8/4
3 Ampicillin/Sulbactam 16/8 ≤8/4 ≤8/4 ≤8/4
4 Ampicillin >16 >16 16 ≤8
5 Aztreonam >16 ≤8 ≤8 ≤8
6 Cefazolin 16 ≤8 ≤8 ≤8
7 Cefepime >16 ≤8 ≤8 ≤8
8 Cefotaxime >32 ≤8 ≤8 ≤8
9 Cefotetan >32 ≤16 ≤16 ≤16
10 Cefoxitin >16 ≤8 ≤8 ≤8
11 Ceftazidime >16 ≤8 ≤8 ≤8
12 Cefuroxime >16 ≤4 ≤4 ≤4
13 Ceftriaxone ≤8 ≤8 ≤8 ≤8
14 Cephalothin >16 ≤8 ≤8 ≤8
15 Chloramphenicol >16 ≤8 ≤8 ≤8
16 Ciprofloxacin ≤1 ≤1 ≤1 ≤1
17 Gatifloxacin ≤2 ≤2 ≤2 ≤2
18 Gentamicin >8 ≤4 ≤4 ≤4
19 Imipenem ≤4 ≤4 ≤4 ≤4
20 Levofloxacin ≤2 ≤2 ≤2 ≤2
21 Meropenem ≤4 ≤4 ≤4 ≤4
22 Moxifloxacin ≤2 ≤2 ≤2 ≤2
23 Nitrofurantoin >64 >64 >64 >64
24 Norfloxacin ≤4 ≤4 ≤4 ≤4
25 Piperacillin ≤16 ≤16 ≤16 ≤16
26 Piperacillin/Tazobactam ≤16 ≤16 ≤16 ≤16
27 Tetracycline >8 >8 >8 >8
28 Ticarcillin 64 ≤16 ≤16 ≤16
29 Tobramycin >8 ≤4 ≤4 ≤4
30 Trimethoprim/Sulfamethoxazole ≤2/38 ≤2/38 ≤2/38 ≤2/38
31 ESBL-a Scrn >4 ≤4 ≤4 ≤4
32 ESBL-b Scrn >1 ≤1 ≤1 ≤1
Gr: Group; MIC data are presented in µg/mL; ESBL-a, b Scrn: Extended-Spectrum 
β-Lactamase Screen
Table 2: Effect of biofield treatment on minimum inhibitory concentration (MIC) of 
Providencia rettgeri. 
S. No. Code Biochemical
Gr.I 
Control
Gr.II 
day 5
Gr.II 
day 10
Gr.III 
day 10
1 ACE Acetamide - - - -
2 ADO Adonitol + + + +
3 ARA Arabinose + + + -
4 ARG Arginine - - - -
5 CET Cetrimide - - - -
6 CF8 Cephalothin + - - -
7 CIT Citrate + + + +
8 CL4 Colistin + + + +
9 ESC Esculin hydrolysis + + + +
10 FD64 Nitrofurantoin + + + +
11 GLU Glucose + + + +
12 H2S Hydrogen sulfide + + + -
13 IND Indole + + + +
14 INO Inositol + + + +
15 K4 Kanamycin + - - -
16 LYS Lysine + + + -
17 MAL Malonate + + + -
18 MEL Melibiose + + + -
19 NIT Nitrate + + + +
20 OF/G Oxidation-fermentation + + + +
21 ONPG Galactosidase + + + -
22 ORN Ornithine + + + -
23 OXI Oxidase - - - -
24 P4 Penicillin + + + +
25 RAF Raffinose + + + -
26 RHA Rhamnose + + + -
27 SOR Sorbitol + + + -
28 SUC Sucrose + + + -
29 TAR Tartarate - + - -
30 TDA Tryptophan deaminase - - + +
31 TO4 Tobramycin + - - -
32 URE Urea + + + +
33 VP Voges-Proskauer + + + -
Gr: Group; - (Negative); + (Positive)
Table 3: Effect of biofield treatment on Providencia rettgeri to biochemical reactions.
Feature
Gr.I
Control
Gr.II
day 5
Gr.II
day 10
Gr.III
day 10
Biotype 7776 5376 7776 5374 7776 5774 4064 0644
Organism 
Identification Name P. rettgeri P. rettgeri P. rettgeri P. rettgeri
Gr: Group
Table 4: Effect of biofield treatment on Providencia rettgeri to biotype.
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alignment and assessment of the gene sequences data were performed 
by comparing with the sequences available in gene bank database of 
NCBI, using the algorithm BLASTn program. The phylogenetic tree 
was constituted using BLAST-Webpage (NCBI). Based on nucleotides 
homology and phylogenetic analysis, the Sample 3A (P. rettgeri) showed 
the genetic similarity with Proteus mirabilis (GenBank Accession 
Number: AY820623) with 100% identity of gene sequencing data. 
Ten different related bacterial species and P. rettgeri were considered 
as Operational Taxonomic Unites (OTUs) in order to investigate the 
phylogenetic relationship of P. rettgeri among other ten related species 
(Figure 1). Total 1495 base nucleotide of 16S rDNA gene sequences 
were analysed by multiple alignments using ClustalW of MEGA3.1 
program [29]. Numbers of base substitutions per site from pairwise 
distance analysis between sequences (11 sequences) are shown in 
Table 5. Based on the phylogenetic tree and 16S rDNA sequencing, the 
nearest homolog genus-species of P. rettgeri was found to be Proteus 
vulgaris (Accession No. DQ499636). Some other close homologs of P. 
rettgeri can be found from the alignment as indicated in Table 5. 
Discussion 
Discovery of antimicrobial was a turning point in human history 
that revolutionized medication in several aspects, and saved the 
countless lives so far. Unfortunately, these wonder drugs have been 
accompanied by the quick emergence of resistant microbes. The 
extended spectrum ß-lactam (ESBL) antibiotics were widely used to 
cure the severe Gram-negative infections but due to production of 
extended spectrum β-lactamases (ESBLs) in the microorganism these 
ESBL antibiotics are now almost ineffective [30,31]. Similarly, the P. 
rettgeri has also acquired the antimicrobial resistance due to producing 
of β-lactamase enzyme and become a considerable threat to the human 
beings [4].
Research study suggests that most of the clinical isolates of P. rettgeri 
were found resistant to older cephalosporin, penicillin, fosfomycin 
and to antibiotics to which other Enterobacteriaceae species are also 
resistant [32]. Our experimental control sample (P. rettgeri) showed 
similar sensitivity and resistant pattern of tested antimicrobials. The 
treated sample of P. rettgeri exhibited the alteration in antimicrobial 
susceptibility from resistant to susceptible or inducible β-lactamases. 
The antimicrobials like amikacin, chloramphenicol, and gentamicin 
were converted from resistant (control) to susceptible with about 
2-folds decrease in the MIC values. Likewise cefoxitin, ceftazidime, 
cephalothin, and aztreonam were converted from resistant to inducible 
β-lactamase, in entire treated groups with about 2-folds decrease in 
the MIC values. The highest decrees (i.e., 4-folds) in MIC value were 
observed for cefotaxime and ticarcillin in the entire treated sample. 
Overall, different class of antimicrobials showed significant effect after 
AN 1 2 3 4 5 6 7 8 9 10 11
DQ499636 1 — 0.981 0.993 0.964 0.992 0.963 0.991 0.951 0.948 0.992 0.991
DQ885259 2 0.019 — 0.983 0.963 0.983 0.962 0.982 0.957 0.953 0.985 0.982
AF008582 3 0.007 0.017 — 0.962 0.992 0.960 0.998 0.954 0.951 0.992 0.998
DQ205449 4 0.036 0.037 0.038 — 0.961 0.999 0.960 0.949 0.947 0.962 0.960
DQ885262 5 0.008 0.017 0.008 0.039 — 0.960 0.990 0.951 0.948 0.999 0.990
DQ205448 6 0.037 0.038 0.040 0.001 0.040 — 0.959 0.948 0.945 0.960 0.959
AY820623 7 0.009 0.018 0.002 0.040 0.010 0.041 — 0.952 0.948 0.991 1.000
AM040489 8 0.049 0.043 0.046 0.051 0.050 0.052 0.048 — 0.988 0.951 0.952
AM040490 9 0.052 0.047 0.050 0.053 0.052 0.055 0.052 0.013 — 0.948 0.948
DQ885257 10 0.008 0.015 0.008 0.038 0.001 0.040 0.009 0.050 0.052 — 0.991
Sample 3A 11 0.009 0.018 0.002 0.040 0.010 0.041 0.000 0.048 0.052 0.009 —
AN, GenBank Accession Number
Figure 1: Distance matrix based on nucleotide sequence homology (Using Kimura-2 Parameter).
Alignment View ID Alignment results Sequence description
3A 0.93 Sample studied
AY820623 0.93 Proteus mirabilis
AF008582 0.94 Proteus mirabilis
DQ499636 0.94 Proteus vulgaris
DQ885262 0.98 Proteus hauseri strain NCTC 4175
DQ885257 0.98 Proteus vulgaris strain ATCC 29905
DQ885259 0.92 Proteus myxofaciens strain NCIMB 13273
DQ205449 0.9 Xenorhabdus hominickii strain KR05
DQ205448 0.89 Xenorhabdus hominickii strain KR01
AM040489 0.93 Providencia rustigianii type strain DSM 4541
AM040490 0.88 Providencia heimbachae type strain DSM 3591
Table 5: The closest sequences of Providencia rettgeri from sequence alignment using NCBI GenBank and ribosomal database project (RDP).
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biofield treatment viz. β-Lactam penicillin (ampicillin/sulbactam), 
cephalosporin (cefazolin, cefepime, cefotetan, and cefuroxime), 
monobactum (azetronan), and aminoglycosides (tobramycin and 
amikacin). In addition, the treated sample of P. rettgeri also showed the 
considerable alteration in biochemical reactions patterns. The biotype 
number of P. rettgeri was also changed from 7776 5376 (control) to 7776 
5374, 7776 5774, in Gr.II on day 5 and 10, respectively, and 4064 0644 
in Gr.III on day 10 (Table 4). Based on the BLASTn analysis, the sample 
3A was identified as P. mirabilis with 100% similarity in gene sequence. 
The phylogenetic tree diagram (Figure 2) anticipated the closest species 
of P. rettgeri to be as Proteus vulgari. The present study revealed that 
biofield treatment could alter the sensitivity of antimicrobials against P. 
rettgeri. Based on these results, it seems that biofield treatment can be a 
better alternate of existing drug therapy in future. 
Conclusions
Altogether, these results suggest that Mr. Trivedi’s biofield treatment 
has a significant impact on antimicrobial susceptibility, MIC value, 
biochemical reactions pattern, and biotype number of P. rettgeri. 
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